NCT04593173

Unknown

Diabetic Cardiomyopathy

University Hospital, Strasbourg, France Source

Compare

Other study identifiers

Sponsor study identifier

7905

Study Type

observational

Estimated enrollment

77

Locations

1 country

Sites

1

Timeline

Study Start

October 1, 2020

Actual (reported)

Primary Completion

September 1, 2021

Actual (reported)

Study Completion

November 1, 2021

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

Diabetes represents one of the 10 leading causes of death in the world and concerns 5% of the French population (\> 3.3 million patients). About 30% of diabetic patients will develop heart failure. The specific and early identification of diabetic cardiomyopathy at a subclinical stage (asymptomatic patients with normal LVEF) will thus make it possible to predict the risk of the onset of heart failure and to strengthen their monitoring and further adapt their treatment.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 77 participants
Study completion date: November 1, 2021
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
October 1, 2020
Actual (reported)
First Submitted
October 13, 2020
Actual (reported)
First Posted
October 19, 2020
Actual (reported)
Primary Completion
September 1, 2021
Actual (reported)
Study Completion
November 1, 2021
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: October 12, 2021
Status Verified: October 2020
Last Update Submitted: October 11, 2021

Conditions

Diabetic Cardiomyopathies

Keywords

DiabetesCardiomyopathyDiabetic CardiomyopathiesType 2 diabetesEchocardiographyLeft ventriclestrain 2D and 3D

Outcome Measures

Primary Outcomes (1)

Analysis of Value of 2D and 3D Left Ventricular Strains in Echocardiography in Type 2 of diabetic Patients
The files analysed retrospectily from April 15, 2015 to April 30, 2019 will be examined]

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Type 2 diabetic and hypertensive patients, treated in the Internal Medicine and Diabetology Services of Strasbourg University Hospitals, between 04/15/2015 to 04/30/2019.

You may qualify if:

Adult patient (≥18 years old)

Sponsors & Collaborators

University Hospital, Strasbourg, France
Otherlead

Study Sites (1)

Service de Physiologie et d'Explorations Fonctionnelles

Strasbourg, Starsbourg, 67091, France

RECRUITING

Samy TALHA, MDCONTACT33 3 69 55 13 68 samy.talha@chru-strasbourg.fr

Saïd CHAYER, PhD, HDRCONTACT33 3 88 11 66 90 said.chayer@chru-strasbourg.fr

Samy TALHA, MDPRINCIPAL INVESTIGATOR

Emmanuel ANDRES, MD, PhDSUB INVESTIGATOR

Bernard GENY, MD, PhDSUB INVESTIGATOR

MeSH Terms

Conditions

Diabetic CardiomyopathiesDiabetes MellitusCardiomyopathiesDiabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesDiabetes ComplicationsEndocrine System DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Central Study Contacts

Samy TALHA, MD

CONTACT

33 3 69 55 13 68 samy.talha@chru-strasbourg.fr

Saïd CHAYER, PhD, HDR

CONTACT

33 3 88 11 66 90

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: OTHER
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

October 13, 2020

First Posted

October 19, 2020

Study Start

October 1, 2020

Actual (reported)

Primary Completion

September 1, 2021

Actual (reported)

NCT05102851

Impact of Prediabetes on Acute Coronary Syndrome

Completed

NCT03206294

Impact of Pharmacist in Cardiology Service

Not ApplicableCompleted

NCT00628056

Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in Diabetes

Phase 1/2Unknown

NCT04591639

The DAPA-MEMRI Trial

Not ApplicableCompleted

NCT05556005

Efficacy of Trimetazidine in Diabetic Patients

Phase 2Unknown

NCT03299790

Effect of High-intensity Interval Training on Cardiac Function and Regulation of Glycemic Control in Diabetic Cardiomyopathy

Not ApplicableCompleted

Type 2 diabetic and hypertensive subjects, cardiac asymptomatic, without myocardial ischemia documented by Dobutamine stress ultrasound (ESD), having at least 1 additional CV risk factor among: dyslipidemia, active or stopped smoking for less than 3 years, family history (1st degree relationship) of major CV accident before age 60, obliterating arteriopathy of the lower limbs and / or carotid atheroma, or proteinuria.

Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

You may not qualify if:

Patient who expressed his opposition to participating in the study
Valvular heart disease (moderate to severe valve disease), hypertrophic or dilated (MVGi\> 95 g / m2 in women and MVGi\> 115 g / m2 in men), chronic pulmonary;
History of cardiotoxic chemotherapy;
Subject under legal protection, under guardianship or under guardianship.

Contact the study team to confirm eligibility.

Patrick OHLMANN, MD, PhD

SUB INVESTIGATOR

Soraya EL GHANNUDI-ABDO, MDSUB INVESTIGATOR

Dominique PARIS-BOCKEL, MDSUB INVESTIGATOR

Marc-André GOLTZENE, MDSUB INVESTIGATOR

said.chayer@chru-strasbourg.fr

Study Completion

November 1, 2021

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

October 12, 2021

Record last verified: 2020-10

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT04593173
Data provider: ClinicalTrials.gov
Source updated: 2021-10-12
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:31:12 UTC

Locations

FR(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations